Overall rank by patents
#26,912
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 2 technology areas, active 2015–2019. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
Mynosys holds 10 US patents across 2 technology areas, rank #26,912 of 50,000 tracked assignees.
Mynosys Cellular Devices, Inc. has been granted 10 US utility patents between 2015 and 2019, placing Mynosys Cellular Devices, Inc. at rank #26,912 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 23.7 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Mynosys Cellular Devices, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Mynosys sits between Multisensor Scientific, Inc. (10 patents, rank #26,908) and Nanjing Institute OF Environmental Sciences, Ministry OF Ecology AND Environment (10 patents, rank #26,916) - the closest US assignees by grant volume. The composite Innovation Score of 27.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 10 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Mynosys Cellular Devices, Inc.'s 23.7 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Mynosys Cellular Devices, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
MultiSensor Scientific, Inc.
10 patents
Murtech, Inc.
10 patents
Mydor, LLC
10 patents
Myndshft Technologies, Inc.
10 patents
Myntra Designs Private Limited
10 patents
Mühlbauer GmbH & Co. KG
10 patents
N3N CO., LTD.
10 patents
NANJING INSTITUTE OF ENVIRONMENTAL SCIENCES, MINISTRY OF ECOLOGY AND ENVIRONMENT
10 patents
Mynosys Cellular Devices, Inc.
10 patents
What this shows Mynosys holds 10 patents at rank #26,912, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #26,912 in granted patent volume.
Other assignees with the most granted patents in Mynosys's primary technology class.
Mynosys's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
28 Top 76% higher than 24% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 10.0% |
| 2016 | 3 | 30.0% |
| 2018 | 2 | 20.0% |
| 2019 | 4 | 40.0% |
Top 2 of 2 technology areas
Overall rank by patents
#26,912
Across all tracked assignees
27.5 out of 100
How to use this portfolio
Mynosys's 10 grants land it in the top 76% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.